Reuter U, et al. Long-term efficacy and safety of erenumab: Results from 64 weeks of the LIBERTY study. IHC-OR-006. IHC 2019 5-8 sept. Dublin, Ierland.
Vroegtijdig kanker ontdekken in druppel bloed
nov 2020 | Borstkanker, Longoncologie, Neuro-oncologie